Background
==========

Randomised Controlled Trials (RCTs) are considered the \'Gold Standard\' test of clinical effectiveness \[[@B1]\] and such trials are increasingly being used in evaluations of non-clinical interventions. There are many ways of classifying RCTs, such as the extent of blinding, method of randomisation (including whether interventions will be randomised at individual or cluster level) and the inclusion (or not) of a preference arm \[[@B2]\]. A further classification is the way in which participants are exposed to the intervention \[[@B2]\] and we refer to this as the \'design\' of the RCT. This paper provides a review of studies employing a particular design, known as a \'stepped wedge\'.

In a stepped wedge design, an intervention is rolled-out sequentially to the trial participants (either as individuals or clusters of individuals) over a number of time periods. The order in which the different individuals or clusters receive the intervention is determined at random and, by the end of the random allocation, all individuals or groups will have received the intervention. Stepped wedge designs incorporate data collection at each point where a new group (step) receives the intervention. An example of the logistics of a stepped wedge trial design is shown in Figure [1](#F1){ref-type="fig"}, which shows a stepped wedge design with five steps. Data analysis to determine the overall effectiveness of the intervention subsequently involves comparison of the data points in the control section of the wedge with those in the intervention section.

![Example of a stepped wedge study design.](1471-2288-6-54-1){#F1}

Cook and Campbell were possibly the first authors to consider the potential for *experimentally staged introduction*in a situation when an innovation cannot be delivered concurrently to all units \[[@B3]\]. The first empirical example of this design being employed is in the Gambia Hepatitis Study, which was a long-term effectiveness study of Hepatitis B vaccination in the prevention of liver cancer and chronic liver disease \[[@B4]\]. It is from this latter study that we have taken the term \'stepped wedge\'.

There are two key (non-exclusive) situations in which a stepped wedge design is considered advantageous when compared to a traditional parallel design. First, if there is a prior belief that the intervention will do more good than harm \[[@B5]\], rather than a prior belief of equipoise \[[@B6]\], it may be unethical to withhold the intervention from a proportion of the participants, or to withdraw the intervention as would occur in a cross-over design. Second, there may be logistical, practical or financial constraints that mean the intervention can only be implemented in stages \[[@B3]\]. In such circumstances, determining the order in which participants receive the intervention at random is likely to be both morally and politically acceptable and may also be beneficial for trial recruitment \[[@B7]\]. An example of an intervention where a stepped wedge design may be appropriate in evaluation is a school-based anti-smoking campaign that is delivered by one team of facilitators who travel to each participating school in turn.

It is also important to note that the stepped wedge design is likely to lead to a longer trial duration than a traditional parallel design, particularly where effectiveness is measured immediately after implementation. The design also imposes some practical implementation challenges, such as preventing contamination between intervention participants and those waiting for the intervention and ensuring that those assessing outcomes are blind to the participant\'s status as intervention or control to help guard against information bias. Blinding assessors is particularly important since it is almost impossible to blind participants or those delivering the intervention, since both will be aware of the \'step\' from control to intervention status. As will be shown in this paper, a variety of approaches to statistical analysis have been employed empirically, in part due to the complex nature of the analysis itself.

The potential benefits of employing a stepped wedge design can be illustrated by considering the £20 m evaluation of the Sure Start programme in the UK \[[@B8]\]. The Department for Education and Skills ruled out a cluster trial where the deprived areas identified as in need of Sure Start would be randomised to either receive the intervention or act as controls, since to intervene in some areas but not in others was judged unacceptable. The evaluation has instead used a non-randomised control group, consisting of 50 \"Sure Start-to-be\" communities, compared to the 260 Sure Start intervention communities. However the local programmes, evaluated by Belskey et al. \[[@B9]\] were in fact introduced in six waves between 1999 and 2003 \[[@B10]\]. This implementation strategy actually provided an excellent opportunity for a stepped wedge study design, which would have met both ethical and scientific imperatives. Determining the order in which communities received the intervention at random would have been demonstrably impartial and hence a fair way to allocate resources. From the scientific point of view, randomisation would eliminate allocation bias and the stepped wedge deign would have offered a further opportunity to measure possible effects of time of intervention on the effectiveness of the intervention. Since no pre-intervention measurements were undertaken, it was also impossible to separate the effects of the Sure Start programmes from any underlying temporal changes within each community and these effects could also have been investigated through the use of a stepped wedge design.

In this paper, we provide a review of studies employing a stepped wedge design. The review includes studies based on both individual and cluster allocations and is not restricted to RCTs. Indeed, we do not apply any methodological filters. The aim of the review is to determine the extent to which the stepped wedge design has been employed empirically and, for the available studies, to examine the background epidemiology, why researchers decided on a stepped wedge design and methods of data analysis. The review is intended to be systematic and includes trials from all fields. However we would be interested to hear about any further examples that our search may have missed.

Methods
=======

Search strategy
---------------

We searched the Current Controlled Trials Register, the Cochrane Database, Medline, Cinahl, Embase, PsycInfo, Web of Knowledge and Google Scholar for papers and trial protocols using the following phrases: step wedge, stepped wedge, experimentally staged introduction and the nine possible combinations of incremental/phased/staggered and recruitment/introduction/implementation. The search was undertaken in October 2005 and repeated in March 2006. In addition, we checked the citations of the original Gambia Hepatitis Study and the references and citations of other relevant papers. We included any relevant papers in the English language that employed a stepped wedge design (although as indicated by the search terms the authors may have used an alternative term to describe their trial design), but did not include any date or subject restrictions. We exclude multiple baseline designs, which are generally applied to analyse the response of single subjects to an intervention and where analysis is undertaken separately for each individual, since exposure to the intervention is often delayed until a stable baseline has been achieved rather than being determined randomly \[[@B11]\]. Given our focus on study design, we exclude any follow-up papers presenting further results and analysis of a study already included in the review.

Data extraction and analysis
----------------------------

Data were extracted from studies included in the review onto a standard proforma (see [Additional file 1](#S1){ref-type="supplementary-material"}) in three main categories: basic information about the trial (including epidemiology, intervention and trial size), reasons for using a stepped wedge design and methods of data analysis. Data were transposed from the proformas to a database that was subsequently interrogated to elicit summary information and key themes in each of the three categories across all of the studies.

Results and discussion
======================

Yield
-----

Figure [2](#F2){ref-type="fig"} shows the results of our search which identified only 12 papers or protocols (referred to as studies) in which a stepped wedge design was described. The studies included in the review described their study design as either stepped wedge or phased introduction/implementation. We contacted the authors of the conference proceeding report identified by a citation check and a protocol identified by the Controlled Trials Register but were unable to obtain sufficient information about these trials to include them in our review. Three of the included studies \[[@B12]-[@B14]\] are protocols describing trials that were being designed or implemented rather than providing results of the evaluation. Basic information about each of the included studies is shown in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}.
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###### 

Study epidemiology

  Lead Author                          Date   Disease                                     Country             Setting
  ------------------------------------ ------ ------------------------------------------- ------------------- -----------------------------------------------
  Gambia Hepatitis Study Group \[4\]   1987   Liver cancer                                Gambia              Regions
  Cook \[17\]                          1996   Substance abuse                             USA                 Workplace
  Wilmink \[19\]                       1999   Ruptured abdominal aortic aneurysms         UK                  GP surgeries
  Somerville \[14\]                    2002   Respiratory Health                          UK                  Houses in Watcombe
  Fairley \[15\]                       2003   HIV (Adherence to antiretroviral therapy)   Australia           Sexual health clinic
  Hughes \[12\]                        2003   HIV (Mother to child transmission)          Zambia and Uganda   Health clinics
  Levy \[16\]                          2004   HIV (Adherence to antiretroviral therapy)   Australia           Ambulatory care clinic in a tertiary hospital
  Priestly \[22\]                      2004   Critical care                               UK                  NHS hospital trust
  Bailey \[18\]                        2004   Water-borne diseases                        South Africa        Households
  Grant \[20\]                         2005   TB in HIV+ men                              South Africa        Company health centre
  Ciliberto \[21\]                     2005   Childhood malnutrition                      Malawi              National rehabilitation units
  Chaisson \[13\]                      2005   TB in HIV+ men                              Brazil              HIV clinics

###### 

Study interventions

  Lead Author                          Date   Nature of Intervention                                  Level of \'stepping\'    Is \'stepping\' randomised?                Primary outcome measure
  ------------------------------------ ------ ------------------------------------------------------- ------------------------ ------------------------------------------ ------------------------------------------
  Gambia Hepatitis Study Group \[4\]   1987   Hepatitis B vaccination                                 Vaccination team         Yes                                        Liver cancer rates/Vaccine efficacy
  Cook \[17\]                          1996   Educational programme                                   Cohort                   Yes                                        Health Behaviour Questionnaire measures
  Wilmink \[19\]                       1999   Screening programme                                     Surgery and Individual   Surgery -- not stated; individual -- yes   Incidence and mortality of RAAAs
  Somerville \[14\]                    2002   Improvements to housing                                 Sets of houses           Yes                                        Respiratory Health Symptoms
  Fairley \[15\]                       2003   Education programme and individual plans                Not stated               Yes                                        Proportion of missed doses
  Hughes \[12\]                        2003   Provision of Nevirapine to pregnant HIV+ women          Pre-natal clinic         Not stated                                 Mother to child HIV transmission
  Levy \[16\]                          2004   Education programme and individual plans                Individual               Yes                                        Proportion of missed doses
  Priestly \[22\]                      2004   Critical care outreach teams                            Ward                     Yes -- in pairs                            Rate of in-hospital deaths
  Bailey \[18\]                        2004   Provision of piped water to house yards                 District                 Not stated                                 Water quality
  Grant \[20\]                         2005   Screening and Isoniazid therapy                         Individual               Yes                                        TB episodes \>90 days after clinic entry
  Ciliberto \[21\]                     2005   Home-based therapy with ready to use therapeutic food   Rehab unit               Not stated                                 Attainment WHZ score \>-2/Death
  Chaisson \[13\]                      2005   Screening and treatment for TB                          Clinic                   Yes                                        TB Incidence

###### 

Study size

  Lead Author                          Date   Number of \'steps\'                    Number of participants:                                   Time period between steps
  ------------------------------------ ------ -------------------------------------- ------------------------- ------------------------------- ---------------------------------------
                                                                                     **Intervention**          **Control**                     
                                                                                                                                               
  Gambia Hepatitis Study Group \[4\]   1987   17                                     61,065                    63,512                          10--12 weeks
  Cook \[17\]                          1996   2                                      371                       Not stated                      
  Wilmink \[19\]                       1999   Individual -- 13,147                   29,713 person years       70,298 person years             Not stated -- total 6 years
  Somerville \[14\]                    2002   2                                      119                       1 year                          
  Fairley \[15\]                       2003   43                                     43                        Not stated -- total 20 weeks    
  Hughes \[12\]                        2003   2                                      Aim: 304                  Aim: 304                        7 months (4 intervention, 3 wash-out)
  Levy \[16\]                          2004   Not stated (2 randomisation periods)   68                        Not stated -- total 20 weeks    
  Priestly \[22\]                      2004   8                                      2,903                     4,547                           4 weeks
  Bailey \[18\]                        2004   4                                      400                       About 3 months                  
  Grant \[20\]                         2005   1,655                                  1,655                     Not stated -- total 26 months   
  Ciliberto \[21\]                     2005   7                                      992                       186                             3 weeks
  Chaisson \[13\]                      2005   29                                     Not stated                1 month                         

Notes:

The number of individuals is based on recruitment to the trial, rather than completed follow-up numbers.

Where only one figure for the number of participants is given, each individual/household participant receives the intervention at some stage during the trial.

In the Wilmink study \[19\], individuals cross-over from control to intervention at various points, but contribute person-years of data to both sections of the wedge.

In the remaining four studies with both \'intervention\' and \'control\' participants \[4, 12, 21, 22\], the unit of randomisation is the clinic or ward and hence an individual visiting the clinic/ward while it is in the control section of the wedge will not receive the intervention. Individuals visiting the clinic/ward once it has crossed-over to intervention will then contribute data to the intervention section of the wedge.

Epidemiology and study details
------------------------------

While the small sample makes generalisations difficult, the stepped wedge design appears to be primarily used in evaluating interventions in developing countries, with HIV the most common disease addressed (Table [1](#T1){ref-type="table"}). Table [2](#T2){ref-type="table"} identifies that a number of different interventions were being evaluated, with vaccination, screening and education plans emerging as the most common interventions. Such interventions are likely to have an existing evidence base, adding to intuitive beliefs that the intervention is likely to do more good than harm. It is also possible that the use of the stepped wedge design is increasing, with 9 (75%) of the studies published since 2002.

As shown in Table [2](#T2){ref-type="table"}, three of the studies were randomised (and thus stepped) at the level of the individual and we suspect that Fairley et al. \[[@B15]\] also applied individual-level randomisation, since this study is a precursor to another similar study \[[@B16]\]. The remaining eight studies are cluster trials, with houses, clinics, wards and districts receiving the intervention in each time period. Of the cluster studies, three \[[@B14],[@B17],[@B18]\] are cohort designs (with the same individuals in each cluster in the pre and post intervention steps) and the remainder are repeated cross-section designs (with different individuals in each cluster in the pre and post intervention steps). It is only permissible to include terminal end-points (such as death) in studies with a repeated cross-sectional design: in individual/cohort designs if a participant has died in the control phase, it is impossible for them to die in the intervention stage. Nevertheless, this axiom is violated in one of the cohort designs \[[@B19]\] where incidence and mortality from ruptured abdominal aortic aneurysms are used as end-points. This problem is likely to introduce a \"healthy survivor\" bias \[[@B20]\].

Two of the cluster studies \[[@B12],[@B18]\] did not indicate whether stepping was randomised. In addition, it is not clear whether the order in which Nutritional Rehabilitation Units were allocated to the intervention was determined at random in the study reported by Ciliberto et al. \[[@B21]\], although this is unlikely given that the paper suggests that randomised assignment in which some clusters would not receive the intervention was not possible due to resource constraints and cultural beliefs. However, of the remaining nine studies, only three \[[@B14],[@B20],[@B22]\] provided any detail on the method of randomisation employed and none of these would have fulfilled all of the requirements relating to randomisation (sequence generation, allocation concealment and implementation) detailed in the CONSORT statement or its extension for cluster studies \[[@B23],[@B24]\].

As noted above, it is almost impossible to blind participants or those involved in delivering the intervention from being aware of whether a participant is currently in the control or intervention section of the wedge. This makes blinding of those assessing outcomes particularly important in protecting against information biases, particularly where outcomes are subjective. None of the studies in the sample provided enough detail to determine whether outcome assessments were blinded, with one study \[[@B14]\] deciding not to blind assessors to help maintain response rates. The intervention in this study involved improvements to housing, with health and environmental assessments undertaken in participants\' homes so that participants would not have to travel to a \'neutral\' location.

The studies varied considerably in terms of number of steps and number of participants (Table [3](#T3){ref-type="table"}). It may be relevant to question whether there is a minimum number of steps required for the trial to be classed as a stepped wedge. Three of the studies \[[@B12],[@B14],[@B17]\] include only two steps. In two of these studies \[[@B14],[@B17]\] participants are randomised to two cohorts, with one cohort receiving the intervention while the other cohort served as the control. The control groups subsequently receive the intervention and further evaluation of effectiveness was undertaken, suggestive of the stepped wedge approach. The third study \[[@B12]\] employs what the authors term a \"combined parallel/stepped wedge design\", although only four out of the eight clusters crossed-over from the control to the intervention groups, with all of these clusters crossing-over at the same time. The mean number of steps in the remaining five cluster studies was 13 (range 4--29). Sample size calculations are reported in just five studies \[[@B4],[@B12],[@B13],[@B21],[@B22]\].

Motivations for employing a stepped wedge design
------------------------------------------------

All of the studies bar one \[[@B15]\] identified one or more motivations for employing a stepped wedge design, although the level of detail regarding motivations varied. Four studies \[[@B16],[@B17],[@B20],[@B21]\] reported using a stepped wedge design to prevent ethical objections arising from withholding an intervention anticipated to be beneficial. Practical difficulties with providing the intervention to everyone simultaneously were mentioned in four studies, due to insufficient resources in three \[[@B4],[@B14],[@B21]\] and logistical difficulties in two \[[@B4],[@B18]\]. The authors reported a desire to use an RCT for evaluation in four studies \[[@B4],[@B14],[@B17],[@B22]\] and scientific reasons were given in five studies: allowing individuals/clusters to act as their own controls \[[@B12],[@B19]\] and to detect underlying trends/control for time \[[@B12],[@B13],[@B20],[@B21]\].

Methods of data analysis
------------------------

No two studies use the same methods of analysing data, although most compare outcomes in the intervention and control sections of the stepped wedge across the entire data set. The primary method(s) of data analysis for each study are shown in Table [4](#T4){ref-type="table"}. These methods vary considerably in terms of their complexity and there is insufficient information to determine the appropriateness of each method. Only two studies \[[@B13],[@B14]\] propose a cost-effectiveness analysis. The two studies that apply step-by-step analysis \[[@B4],[@B13]\] provide a separate analysis for each step in the trial, in order to separate out underlying time trends. Of the remaining studies that reported using a stepped wedge design to control for underlying time trends, Grant et al. \[[@B20]\] apply a Poisson random effects model to control for disease progression and Ciliberto et al. \[[@B21]\] use linear and logistic models to consider the effect of month (as a seasonal effect), although the results are not reported. The Hughes et al. \[[@B12]\] protocol includes time as a component in the model, but the analytical approach to be taken is not clear. Cook et al. \[[@B17]\] and Priestly et al. \[[@B22]\] also consider the impact of time on effectiveness. The latter uses matched pairs of wards to control for inter-temporal changes, randomising one ward in each pair to early intervention and one to late intervention. Analysis is then undertaken using a sub-set of three 4-week time periods for each ward pair, comparing the outcomes in intervention and control wards across the same 12-week period.

###### 

Methods of analysis

  Lead Author                          Date   Primary outcome measure                    Method(s) of Analysis
  ------------------------------------ ------ ------------------------------------------ --------------------------------------------------------------------------------------------------------
  Gambia Hepatitis Study Group \[4\]   1987   Liver cancer rates/Vaccine efficacy        Comparisons of incidence rates on a step by step basis to identify vaccine efficacy
  Cook \[17\]                          1996   Health Behaviour Questionnaire measures    Comparison of group means and group by time, gender and education interactions (F-test)
  Wilmink \[19\]                       1999   Incidence and mortality of RAAAs           Poisson likelihood distribution for incidence rates in person years and maximum likelihood rate ratios
  Somerville \[14\]                    2002   Respiratory Health Symptoms                Not stated (description of intervention only)
  Fairley \[15\]                       2003   Proportion of missed doses                 Unpaired t-test of means
  Hughes \[12\]                        2003   Mother to child HIV transmission           Not stated (protocol only)
  Levy \[16\]                          2004   Proportion of missed doses                 Wilcoxon rank-sum test
  Priestly \[22\]                      2004   Rate of in-hospital deaths                 Logistic regression Cox proportional hazard models (length of stay)
  Bailey \[18\]                        2004   Water quality                              Summary statistics only Time series analysis for diarrhoea rates
  Grant \[20\]                         2005   TB episodes \>90 days after clinic entry   Poisson random effects model
  Ciliberto \[21\]                     2005   Attainment WHZ score \>-2/Death            95% CI for differences between groups Linear and logistic regression for effects of covariates
  Chaisson \[13\]                      2005   TB Incidence                               Step by step analysis of incidence Conditional logistic regression Cost-effectiveness analysis

Four of the studies \[[@B4],[@B12],[@B19],[@B21]\] included long term follow-up beyond the period in which stepping took place, since the outcomes to be assessed may occur at a point following the final step (i.e. there is a lag between intervention and outcome).

Conclusion
==========

Our review has identified a number of evaluations where a stepped wedge design was clearly appropriate and where the design can provide sound evidence to guide future practice. However not all of the studies included here would fulfil the methodological requirements for a controlled trial and hence we propose that if a stepped wedge design is to be applied, authors should register their trial on the Controlled Clinical Trials Register and follow appropriate reporting guidelines, such as the CONSORT statement or its equivalent for cluster trials \[[@B23],[@B24]\]. A particular concern is with the lack of blinding of those assessing subjective outcomes. This is important given the difficulties associated with blinding participants and those delivering the intervention from their status as intervention or control, since it will nearly always be evident to both groups when the step from control to intervention occurs.

The heterogeneity of analytical methods applied in the studies suggests that a formal model considering the effects of time would help others planning a stepped wedge trial and we will present our exposition of such a model in a subsequent paper. A recent paper by Hussey and Hughes \[[@B25]\] also provides detail regarding the analysis of stepped wedge designs. Two particular statistical challenges are controlling for inter-temporal changes in outcome variables and accounting for repeated measures on the same individuals over the duration of the trial.

The opportunities arising from modelling the effects of time can be illustrated by considering the stepped wedge design as a multiple arm parallel design, in which the research aims not only to assess intervention effects, but also to determine whether time of intervention (at the extremes intervening early as opposed to intervening late) impacts the effectiveness of the intervention. Such time effects can also include seasonal variations and disease progression: the latter may be particularly relevant when evaluating interventions targeting treatments for HIV. Although a traditional parallel trial design can be used to examine general secular trends it cannot explore the particular relationship between time of intervention and effectiveness.

One limitation of our review is the possibility that our search strategy did not identify all of the studies that have employed a stepped wedge design. In particular, we may have missed \'delayed intervention\' studies with two steps, in which the delayed group receive the intervention after the outcomes from initial intervention group have been evaluated, but where the outcomes of the delayed group are also evaluated. We have included three studies of this nature in this review \[[@B12],[@B14],[@B17]\] although it is questionable whether studies with only two steps should be considered as stepped wedge designs. One reason for this is the limitations for generalisation, particularly with respect to the impact of time on effectiveness.

Considering the scientific advantages of the stepped wedge design, it has rarely been used in practice and hence we advocate the design for evaluating a wide range of interventions, although we are not the first to do so \[[@B26]-[@B28]\]. In terms of interventions likely to do more good than harm, a stepped wedge design may be particularly beneficial in evaluating interventions being implemented in a new setting, where evidence for their effectiveness in the original setting is available, or for patient safety interventions that have undergone careful pre-implementation evaluation to rule out any collateral damage. The stepped wedge design may also be appropriate for cost-effectiveness analyses of interventions that have already been shown to be effective. However, the stepped wedge design requires a longer trial duration than parallel designs and also presents a number of challenges, including both practical and statistical complexity. Hence careful planning and monitoring are required in order to ensure that a robust evaluation is undertaken.
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